New Red Cap Warnings for Extra Strength Tylenol Liver Side Effects
Johnson & Johnson will be adding a new “red cap” warning to its popular Extra Strength Tylenol medication. This change comes amid a growing number of personal injury lawsuits brought by individuals who have suffered from liver injuries after taking the pain medication.
In a report by the Associated Press, Tylenol indicates that, beginning in October, bottles of Extra Strength Tylenol will feature bold red warnings on their caps. Recently, Johnson & Johnson has fallen under heavy criticism for allegedly failing to provide sufficient warnings about the risk of liver damage linked to acetaminophen side effects.
Though the public and medical community have long been aware of the potentialfor liver damage linked to acetaminophen, the active ingredient in Tylenol, critics blame excessive marketing of the pain medication on a recent increase in Tylenol liver injuries. Every year, more than 50,000 Americans pay visits to hospital emergency rooms because of Tylenol liver damage, and up to 450 people die from this side effect. Other popular drugs that carry acetaminophen include Sudafed, NyQuil, and Excedrin.
In 2011, Johnson & Johnson reduced the recommended daily dose of Tylenol to 3,000 mg from 4,000 mg. Still, it has been claimed that the 500 mg tablets of Extra Strength Tylenol may pose a heightened risk of overdose and subsequent liver damage.
In multiple Tylenol liver damage personal injury lawsuits, plaintiffs claim that Johnson & Johnson has valued profit over patient safety by failing to provide adequate warnings about the risk of liver damage linked to the product. At this time, there are more than 80 Tylenol lawsuits pending in American courts. If you believe your liver problems may be linked to Tylenol, contact an attorney at Berkowitz and Hanna LLC to schedule a legal evaluation of your claim.